BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29925948)

  • 1. Altered exocrine function can drive adipose wasting in early pancreatic cancer.
    Danai LV; Babic A; Rosenthal MH; Dennstedt EA; Muir A; Lien EC; Mayers JR; Tai K; Lau AN; Jones-Sali P; Prado CM; Petersen GM; Takahashi N; Sugimoto M; Yeh JJ; Lopez N; Bardeesy N; Fernandez-Del Castillo C; Liss AS; Koong AC; Bui J; Yuan C; Welch MW; Brais LK; Kulke MH; Dennis C; Clish CB; Wolpin BM; Vander Heiden MG
    Nature; 2018 Jun; 558(7711):600-604. PubMed ID: 29925948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.
    Babic A; Rosenthal MH; Sundaresan TK; Khalaf N; Lee V; Brais LK; Loftus M; Caplan L; Denning S; Gurung A; Harrod J; Schawkat K; Yuan C; Wang QL; Lee AA; Biller LH; Yurgelun MB; Ng K; Nowak JA; Aguirre AJ; Bhatia SN; Vander Heiden MG; Van Den Eeden SK; Caan BJ; Wolpin BM
    Nat Commun; 2023 Jul; 14(1):4317. PubMed ID: 37463915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
    Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
    Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting.
    Cole CL; Bachman JF; Ye J; Murphy J; Gerber SA; Beck CA; Boyce BF; Muthukrishnan G; Chakkalakal JV; Schwarz EM; Linehan D
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):731-745. PubMed ID: 33960737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.
    Babic A; Rosenthal MH; Bamlet WR; Takahashi N; Sugimoto M; Danai LV; Morales-Oyarvide V; Khalaf N; Dunne RF; Brais LK; Welch MW; Zellers CL; Dennis C; Rifai N; Prado CM; Caan B; Sundaresan TK; Meyerhardt JA; Kulke MH; Clish CB; Ng K; Vander Heiden MG; Petersen GM; Wolpin BM
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2062-2069. PubMed ID: 31533940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic exocrine insufficiency in LXRbeta-/- mice is associated with a reduction in aquaporin-1 expression.
    Gabbi C; Kim HJ; Hultenby K; Bouton D; Toresson G; Warner M; Gustafsson JA
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15052-7. PubMed ID: 18806227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
    Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice.
    Xu M; Chang HH; Jung X; Moro A; Chou CEN; King J; Hines OJ; Sinnett-Smith J; Rozengurt E; Eibl G
    BMC Cancer; 2018 Aug; 18(1):797. PubMed ID: 30086728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Exocrine Insufficiency in Pancreatic Cancer.
    Vujasinovic M; Valente R; Del Chiaro M; Permert J; Löhr JM
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28241470
    [No Abstract]   [Full Text] [Related]  

  • 12. The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes.
    Dunne RF; Roeland EJ
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):897-910. PubMed ID: 36154783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
    Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
    Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer: A Vicious Cycle.
    Aziz MH; van der Meulen J; Mustafa DAM; van Eijck CHJ
    Pancreas; 2022 Sep; 51(8):923-929. PubMed ID: 36607936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
    Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
    Elife; 2020 May; 9():. PubMed ID: 32391790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma.
    Chang HH; Eibl G
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
    Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
    Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.
    Adamska A; Domenichini A; Capone E; Damiani V; Akkaya BG; Linton KJ; Di Sebastiano P; Chen X; Keeton AB; Ramirez-Alcantara V; Maxuitenko Y; Piazza GA; De Laurenzi V; Sala G; Falasca M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):312. PubMed ID: 31378204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.
    Martínez-Romero C; Rooman I; Skoudy A; Guerra C; Molero X; González A; Iglesias M; Lobato T; Bosch A; Barbacid M; Real FX; Hernández-Muñoz I
    J Pathol; 2009 Oct; 219(2):205-13. PubMed ID: 19585519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of endocrine and exocrine insufficiency after resection of a benign tumour of the pancreas.
    Neophytou H; Wangermez M; Gand E; Carretier M; Danion J; Richer JP
    Ann Endocrinol (Paris); 2018 Apr; 79(2):53-61. PubMed ID: 29526248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.